Chemical affinity matrix-based identification of prohibitin as a binding protein to anti-resorptive sulfonyl amidine compounds

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 2, 2011, Pages 727-729

  Chang, Sung Youn ^a   Bae, Su Jung ^a   Lee, Myung Yun ^a   Baek, Seung Hwa ^a   Chang, Sukbok ^b   Kim, Seong Hwan ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Chemical affinity matrix; Chemical proteomics; Prohibitin

Indexed keywords

5 CHLORO 1 (2,6 DIMETHYLPIPERIDIN 1 YL) N TOSYLPENTAN 1 IMINE; AMIDINE; PROHIBITIN; UNCLASSIFIED DRUG;

ARTICLE; DRUG PROTEIN BINDING; DRUG SYNTHESIS;

AMIDINES; ANIMALS; BONE DENSITY CONSERVATION AGENTS; CELL LINE; CHROMATOGRAPHY, AFFINITY; MICE; PROTEIN BINDING; PROTEOMICS; REPRESSOR PROTEINS; SULFINIC ACIDS;

EID: 78651256728     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.11.123     Document Type: Article

References (27)

1. S.-Y. Han, and S.H. Kim Arch. Pharm. Chem. Life Sci. 340 2007 169
2. U. Rix, and G. Superti-Furga Nat. Chem. Biol. 5 2010 616
3. W.J. Boyle, W.S. Simonet, and D.L. Lacey Nature 423 2003 337
4. S. Harada, and G.A. Rodan Nature 423 2003 349
5. M.Y. Lee, M.H. Kim, J. Kim, S.H. Kim, B.T. Kim, I.H. Jeong, S. Chang, S.H. Kim, and S.-Y. Chang Bioorg. Med. Chem. Lett. 20 2010 541
6. I. Bae, H. Han, and S. Chang J. Am. Chem. Soc. 127 2005 2038
7. S.H. Cho, E.J. Yoo, I. Bae, and S. Chang J. Am. Chem. Soc. 127 2005 16046
8. E.J. Yoo, I. Bae, S.H. Cho, H. Han, and S. Chang Org. Lett. 8 2006 1347
9. S. Chang, M. Lee, D.Y. Jung, E.J. Yoo, S.H. Cho, and S.K. Han J. Am. Chem. Soc. 128 2006 12366
10. E.J. Yoo, M. Ahlquist, S.H. Kim, I. Bae, V.V. Fokin, K.B. Sharpless, and S. Chang Angew. Chem., Int. Ed. 46 2007 1730
11. S.H. Cho, and S. Chang Angew. Chem., Int. Ed. 46 2007 1897
12. S.H. Cho, and S. Chang Angew. Chem., Int. Ed. 47 2008 2836
13. E.J. Yoo, and S. Chang Org. Lett. 10 2008 1163
14. E.J. Yoo, M. Ahlquist, I. Bae, V.V. Fokin, K.B. Sharpless, and S. Chang J. Org. Chem. 73 2008 5520
15. 2, 1 mM PMSF, 1% Nonidet P-40 and protease inhibitor cocktail).
16. S.M. Khersonsky, D.-W. Jung, T.-W. Kang, D.P. Walsh, H.-S. Moon, H. Jo, E.M. Jacobson, V. Shetty, T.A. Neubert, and Y.-T. Chang J. Am. Chem. Soc. 125 2003 11804
17. M.H. Kim, Y.L. Choi, J.-N. Heo, Y.K. Min, and S.H. Kim Bull. Korean Chem. Soc. 31 2010 2047
18. Protein sample preparation and its incubation with 2b. RAW264.7 cells were homogenized (1:5, w/v) in buffer A under sonication. The homogenate was then centrifuged at 10,000g for 15 min and 0.5 ml of the supernatant diluted with buffer A (7 mg/ml) was stirred with buffer A-saturated 2b at 4 °C for 15 h. After incubation, the resins were precipitated by centrifugation at 10,000g for 1 min and washed three times with 1 ml of buffer A. The washed beads were then resuspended with 20 μl of SDS sample buffer (100 mM Tris-HCl, 2% sodium dodecyl sulfate, 1% 2-mercaptoethanol, 2% glycerol, 0.01% bromophenol blue, pH 7.6), incubated at 25 °C for 10 min, and subjected to SDS-PAGE followed by the gel staining.
19. Western blot analysis. RAW264.7 cell lysate (40 μg) were incubated with non-conjugated Affi-Gel 10 or 2b at 4 °C for 15 h and centrifuged at 10,000g for 1 min. The supernatant (unbound fractions) was denatured with SDS sample buffer. Then, the pellets were washed twice with buffer A, resuspended with 20 μl of SDS sample buffer and incubated at 25 °C for 10 min for getting bound fractions. Denaturation of unbound and bound fractions was done by boiling and then samples were subjected to 10% polyacrylamide gels. Electrophoresis was performed using the Mini Protean 3 Cell (Bio-Rad). The resolved proteins were transferred to PVDF membrane (Millipore). The membranes were incubated in blocking buffer (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Tween 20, 3% nonfat dry milk) and then incubated with diluted primary antibodies (1:1000) for 2 h at room temperature. Antibodies used in this study were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz). Following the primary antibody reactions, the membranes were washed with blocking buffer three times (15 min each) and then probed with diluted secondary antibodies (1:2000) for 1 h. The membranes were washed three times (15 min each) and developed with SuperSignal West Femto Maximum Sensitivity Substrate (Pierce Biotechnology) using the LAS-3000 luminescent image analyzer (Fuji Photo Film Co., Ltd).
20. M. Artal-Sanz, and N. Tavernarakis Trends Endocrinol. Metab. 20 2009 394
21. C. Osman, C. Merkwirth, and T. Langer J. Cell Sci. 122 2009 3823
22. V. García Palacios, L.J. Robinson, C.W. Borysenko, T. Lehmann, S.E. Kalla, and H.C. Blair J. Biol. Chem. 280 2005 13720
23. M.G. Sørensen, K. Henriksen, M.H. Dziegiel, L.B. Tankó, and M.A. Karsdal DNA Cell Biol. 25 2006 475
24. Y. Imai, S. Kondoh, A. Kouzmenko, and S. Kato Mol. Endocrinol. 24 2010 877
25. J.M. Messier, L.M. Shaw, M. Chafel, P. Matsudaira, and A.M. Mercurio Cell Motil. Cytoskeleton 25 1993 223
26. M.M. Chafel, W. Shen, and P. Matsudaira Dev. Dyn. 203 1995 141
27. S.G. Babb, P. Matsudaira, M. Sato, I. Correia, and S.S. Lim Cell Motil. Cytoskeleton 37 1997 308